BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2017
View Archived Issues
CCAT1 and CCAT2 long noncoding RNAs as novel prognostic biomarkers in colorectal cancer
Read More
Novel role of APLNR gene in regulating the response to cancer immunotherapy
Read More
TFAM overexpression rescues sperm defects in infertile mtDNA mutator mice
Read More
Effective in vivo Mnk1/2 inhibitors identified for blast crisis chronic myelogenous leukemia
Read More
Amgen's cyclopropyloxazines, a new series of BACE1 inhibitors for Alzheimer's disease
Read More
FDA approves Duzallo to treat hyperuricemia associated with gout
Read More
Samsung Bioepis and Takeda begin strategic biologic codevelopment collaboration
Read More
Alkermes begins rolling NDA submission for ALKS-5461 as adjuvant treatment of MDD
Read More
Chiesi discovers new phosphatidylinositol 3-kinase inhibitors
Read More
Novel 5-HT-2 receptor antagonists patented by Shenzhen Targetrx Biotechnology
Read More
Jiangsu Chia Tai Tianqing, Centaurus BioPharma and Lianyungang Ruzhong present new BET inhibitors
Read More
FDA grants orphan drug designation to SY-1425 for AML
Read More
European Commission approves new indication for Soliris in refractory generalized myasthenia gravis
Read More
Ilkos Therapeutic initiates phase II study of S-42909 for leg ulcer healing
Read More
Trovagene's PCM-075 shows synergy with HDAC inhibitor in NHL cell lines
Read More
BioLineRx files regulatory submissions to begin phase III study of BL-8040 in stem cell mobilization
Read More
FDA advises on Cardiome's planned NDA resubmission for Brinavess
Read More
Patient enrollment under way in first-in-human trial of M-8891
Read More
Mavyret now available in U.S. for chronic HCV
Read More
Dr. Reddy's reports out-licensing of DFD-06 to Encore Dermatology
Read More
Sorrento announces contribution to formation of Celularity
Read More